Which drugs does patent 6,004,968 protect, and when does it expire?
Patent 6,004,968 protects EPIVIR and EPIVIR-HBV and is included in two NDAs. There have been zero Paragraph IV challenges on Epivir-HBV and Epivir
Protection for EPIVIR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-four patent family members in forty-three countries.